A total of 2299 new cancer patients were referred to the Northern Israel Oncology Center in 1974 and in 1980. The stage of disease, delay in diagnosis, the responsibility for the delay, and the survival of those referred in 1974 were investigated. At the time of diagnosis, 39% of the patients had lo
The effects of symptoms and delay in seeking diagnosis on stage of disease at diagnosis among women with cancers of the ovary
β Scribed by Elaine M. Smith; Barrie Anderson
- Book ID
- 102668960
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 603 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
This study evaluated characteristics of symptoms, their perceived cause, and delay in seeking a diagnosis associated with stage, grade, and histologic features of disease at diagnosis among incident cancer cases of the ovary (N = 83) identified in the Iowa National Cancer Institute-Surveillance, Epidemiology, and End Results population-based cancer registry. Contrary to clinical impressions, most early-stage cancers produced symptoms and were more likely than hte-stage cancers to cause fatigue and urination problems; however, only irregular menstrual cycles were more likely to convince these patients with early-stage cancers to seek a diagnosis. Late-stage cases were most often accompanied by abdominal pain and swellin& but only pain was likely to convince women to seek a diagnosis. There was no association between delay, perceived cause, or seriousness of symptoms with stage of disease at diagnosis. Women, particularly those with a medical history of high risk factors, should be made aware that apparently benign disease symptoms are characteristic of early ovarian cancer and that this tumor can be found early if they seek medical attention immediately.
π SIMILAR VOLUMES
The present study used structural equation modeling to examine the relationships among disease stage (i.e. Stage II versus Stage IV), age, coping style, and psychological adjustment in 100 women diagnosed with breast cancer. Five separate models were examined: a full model, a mediational model, a de
Quality of life (QOL) has become an important outcome measure in the treatment of cancer patients. QOL mainly has been assessed in clinical trials within selective cancer populations to evaluate the effects of specific therapeutic procedures, whereas comparative analyses with QOL of population-based